Faculty of Medicine, School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong SAR, PR China.
Oncol Rep. 2010 Aug;24(2):547-54.
BAD (BCL-2 antagonist of cell death) is a pro-apoptotic BCL-2 family protein that plays a critical role in the regulation of apoptotic response. This study presents direct evidence that AF1q increased the radiation-induced apoptosis through up-regulation of BAD in human squamous carcinoma A431 cells and the key transcription factor involved is NF-kappaB. The minimal promoter sequence of BAD was identified; the activity was increased in AF1q stable transfectants and decreased upon AF1q siRNA transfection. The NF-kappaB consensus binding sequence is detected on BAD promoter. Inactivation of NF-kappaB by NF-kappaB inhibitor Bay 11-7082 or NF-kappaB p65 siRNA suppressed the expression and promoter activity of BAD; the suppression is more obvious in AF1q stable transfectants which also have an elevated NF-kappaB level. Mutation of putative NF-kappaB motif decreased the BAD promoter activity. The binding of NF-kappaB to the BAD promoter was confirmed by chromatin-immunoprecipitation. These findings indicate that AF1q up-regulation of BAD is through its effect on NF-kappaB and this may hint of its oncogenic mechanism in cancer.
BAD(BCL-2 凋亡蛋白家族拮抗物)是一种促凋亡的 BCL-2 家族蛋白,在调节凋亡反应中起着关键作用。本研究直接证明,AF1q 通过上调人鳞状癌细胞 A431 中的 BAD 增加了辐射诱导的细胞凋亡,而涉及的关键转录因子是 NF-κB。鉴定了 BAD 的最小启动子序列;在 AF1q 稳定转染子中活性增加,而在 AF1q siRNA 转染后活性降低。BAD 启动子上检测到 NF-κB 共有结合序列。NF-κB 抑制剂 Bay 11-7082 或 NF-κB p65 siRNA 失活 NF-κB 抑制了 BAD 的表达和启动子活性;在 AF1q 稳定转染子中抑制更为明显,因为这些细胞也具有升高的 NF-κB 水平。突变潜在的 NF-κB 模体降低了 BAD 启动子活性。染色质免疫沉淀证实了 NF-κB 与 BAD 启动子的结合。这些发现表明,AF1q 上调 BAD 是通过其对 NF-κB 的作用实现的,这可能暗示了其在癌症中的致癌机制。